An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

Science

Volumn 351, Issue 6268, 2016, Pages 77-81

  Haagmans, Bart L ^a   Van Den Brand, Judith M A ^a   Raj, V Stalin ^a   Volz, Asisa ^b   Wohlsein, Peter ^c   Smits, Saskia L ^a   Schipper, Debby ^a   Bestebroer, Theo M ^a   Okba, Nisreen ^a   Fux, Robert ^b   Bensaid, Albert ^d   Foz, David Solanes ^d   Kuiken, Thijs ^a   Baumgärtner, Wolfgang ^c   Segalés, Joaquim ^d,e   Sutter, Gerd ^b   Osterhaus, Albert D M E ^a,c,f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e CENTRE DE RECERCA EN SANITAT ANIMAL CRESA   (Spain)

^f Artemis One Health   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MODIFIED VACCINIA VIRUS ANKARA VACCINE; NEUTRALIZING ANTIBODY; ORTHOPOXVIRUS VACCINE; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS RNA; CORONAVIRUS SPIKE GLYCOPROTEIN; VIRUS ANTIBODY; VIRUS VACCINE;

EXCRETION; HYGIENE; IMMUNITY; RESPIRATORY DISEASE; UNGULATE; VACCINE; VIRUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BRONCHITIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORONAVIRUS INFECTION; DROMEDARY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTION; MUCOSAL IMMUNITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; RECEPTOR BINDING; RHINITIS; RHINORRHEA; RNA TRANSCRIPTION; TRACHEITIS; VACCINATION; VIRUS EXCRETION; VIRUS REPLICATION; ANIMAL; BLOOD; CAMEL; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; GENETICS; HUMAN; IMMUNOLOGY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PHYSIOLOGY; VACCINIA VIRUS; VETERINARY; VIROLOGY; VIRUS SHEDDING;

ANIMALIA; CAMELIDAE; CAMELPOX VIRUS; CAMELUS DROMEDARIUS; CORONAVIRUS; ORTHOPOXVIRUS; VACCINIA VIRUS ANKARA;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CAMELS; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RNA, VIRAL; SPIKE GLYCOPROTEIN, CORONAVIRUS; VACCINIA VIRUS; VIRAL VACCINES; VIRUS SHEDDING;

EID: 84952932413     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aad1283     Document Type: Article

References (32)

1. A. M. Zaki, S. van Boheemen, T. M. Bestebroer, A. D. Osterhaus, R. A. Fouchier, N. Engl. J. Med. 367, 1814-1820 (2012).
2. S. van Boheemen et al., mBio 3, e00473-12 (2012).
3. A. Assiri et al., N. Engl. J. Med. 369, 407-416 (2013).
4. A. Zumla, D. S. Hui, S. Perlman, Lancet 386, 995-1007 (2015).
5. C. B. E. M. Reusken et al., Lancet Infect. Dis. 13, 859-866 (2013).
6. M. A. Müller et al., Emerg. Infect. Dis. 20, 2093-2095 (2014).
7. M. G. Hemida et al., Euro Surveill. 19, 20828 (2014).
8. A. N. Alagaili et al., mBio 5, e00884-14 (2014).
9. B. L. Haagmans et al., Lancet Infect. Dis. 14, 140-145 (2014).
10. Z. A. Memish et al., Emerg. Infect. Dis. 20, 1012-1015 (2014).
11. R. W. Chan et al., Lancet Respir. Med. 2, 813-822 (2014).
12. M. A. Müller et al., Lancet Infect. Dis. 15, 559-564 (2015).
13. C. B. Reusken et al., Emerg. Infect. Dis. 21, 1422-1425 (2015).
14. C. B. Reusken et al., Emerg. Infect. Dis. 20, 1370-1374 (2014).
15. A. I. Khalafalla et al., Emerg. Infect. Dis. 21, 1153-1158 (2015).
16. M. G. Hemida et al., Emerg. Infect. Dis. 20, 1231-1234 (2014).
17. V. S. Raj et al., Nature 495, 251-254 (2013).
18. H. Mou et al., J. Virol. 87, 9379-9383 (2013).
19. L. Du et al., J. Virol. 87, 9939-9942 (2013).
20. F. Song et al., J. Virol. 87, 11950-11954 (2013).
21. A. Volz et al., J. Virol. 89, 8651-8656 (2015).
22. D. R. Adney et al., Emerg. Infect. Dis. 20, 1999-2005 (2014).
23. S. Duraffour, H. Meyer, G. Andrei, R. Snoeck, Antiviral Res. 92, 167-186 (2011).
24. E. de Wit et al., Proc. Natl. Acad. Sci. U.S.A. 110, 16598-16603 (2013).
25. B. L. Haagmans et al., J. Virol. 89, 6131-6135 (2015).
26. H. Vennema et al., J. Virol. 64, 1407-1409 (1990).
27. J. Zhao et al., Proc. Natl. Acad. Sci. U.S.A. 111, 4970-4975 (2014).
28. K. E. Pascal et al., Proc. Natl. Acad. Sci. U.S.A. 112, 8738-8743 (2015).
29. J. Zhao et al., J. Virol. 89, 6117-6120 (2015).
30. K. Muthumani et al., Sci. Transl. Med. 7, 301ra132 (2015).
31. K. J. Stittelaar et al., J. Virol. 74, 4236-4243 (2000).
32. S. M. Hafez et al., Vaccine 10, 533-539 (1992).